ホーム › 炎症性腸疾患 › ニューヨーク › New York City
New York City、NYにおける炎症性腸疾患の臨床試験
New York Cityとその周辺地域（約30マイル以内）の拠点で、炎症性腸疾患に関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
被験者募集中第1相
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
被験者募集中第2相
- Pioneer Clinical Research NY, New York
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
被験者募集中第2相
- Site 037, New York
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
- Icahn School of Medicine at Mount Sinai, New York
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
被験者募集中第3相
- Icahn School of Medicine at Mount Sinai, New York
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
被験者募集中第3相
- Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center/New York Presbyterian, New York
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
被験者募集中第3相
- Weill Cornell Medicine, New York
BOOM-IBD2 Pivotal Clinical Trial
被験者募集中
- Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease
被験者募集中観察研究健康なボランティア歓迎
- Icahn School of Medicine at Mount Sinai, New York
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
被験者募集中観察研究
- New York University, New York
Low Dose IL-2 for the Treatment of Crohn's Disease
被験者募集中第1/2相
- Mount Sinai, New York
Autologous Stem Cell Transplant for Crohn's Disease
被験者募集中第2相
- Icahn School of Medicine at Mount Sinai, New York
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
被験者募集中第4相
- Columbia University Medical Center, New York
Impact of Morning Light Therapy in IBD
被験者募集中
- Mount Sinai Hospital, New York
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
被験者募集中第2相
- Mirador Therapeutics Selected Site, New York
Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease
被験者募集中
- NYU Langone Health, New York
Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
被験者募集中観察研究健康なボランティア歓迎
- Icahn School of Medicine at Mount Sinai, New York
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
被験者募集中観察研究
- New York University, New York
他の都市における炎症性腸疾患の試験
- Boston, MA15件の研究
- Miami, FL9件の研究
- Seattle, WA9件の研究
- Durham, NC8件の研究
- Houston, TX8件の研究
- Orlando, FL8件の研究
- Atlanta, GA8件の研究
- Washington, DC7件の研究
- St. Louis, MO7件の研究
- Philadelphia, PA7件の研究
- Cincinnati, OH7件の研究
- Baltimore, MD6件の研究
New York Cityにおける他の研究
- 乳がん136件の研究
- 非小細胞肺癌121件の研究
- がん（全種類）109件の研究
- 前立腺がん103件の研究
- 転移性癌93件の研究
- 大腸癌78件の研究
- 卵巣がん69件の研究
- 肺がん60件の研究
- 多発性骨髄腫60件の研究
- 膵臓がん60件の研究
- 子宮内膜がん52件の研究
- 急性骨髄性白血病51件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。